Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Our objective was to evaluate the published literature and reach a consensus on the treatment of patients with ACTH-dependent Cushing's syndrome, because there is no recent consensus on the management of this rare disorder. PARTICIPANTS: Thirty-two leading endocrinologists, clinicians, and neurosurgeons with specific expertise in the management of ACTH-dependent Cushing's syndrome representing nine countries were chosen to address 1) criteria for cure and remission of this disorder, 2) surgical treatment of Cushing's disease, 3) therapeutic options in the event of persistent disease after transsphenoidal surgery, 4) medical therapy of Cushing's disease, and 5) management of ectopic ACTH syndrome, Nelson's syndrome, and special patient populations. EVIDENCE: Participants presented published scientific data, which formed the basis of the recommendations. Opinion shared by a majority of experts was used where strong evidence was lacking. CONSENSUS PROCESS: Participants met for 2 d, during which there were four chaired sessions of presentations, followed by general discussion where a consensus was reached. The consensus statement was prepared by a steering committee and was then reviewed by all authors, with suggestions incorporated if agreed upon by the majority. CONCLUSIONS: ACTH-dependent Cushing's syndrome is a heterogeneous disorder requiring a multidisciplinary and individualized approach to patient management. Generally, the treatment of choice for ACTH-dependent Cushing's syndrome is curative surgery with selective pituitary or ectopic corticotroph tumor resection. Second-line treatments include more radical surgery, radiation therapy (for Cushing's disease), medical therapy, and bilateral adrenalectomy. Because of the significant morbidity of Cushing's syndrome, early diagnosis and prompt therapy are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As with Cushing’s disease, it may be helpful to use a cortisol synthesis blocking drug while waiting for definitive treatment (18) and in cases where definitive treatment is not possible.”
From ACTH Antagonists (2016) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Once a diagnosis is conclusively made, the optimal treatment is surgical removal of the tumor – ideally preserving the remaining pituitary function.”
From ACTH Antagonists (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · cited 3×
“excess cortisol secretion by unilateral adrenocortical tumors or by bilateral adrenal hyperplasia or dysplasia (1).”
BackgroundInfluentialSelf-citationValvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054830 · Cited by 884 · cited 1×
“However, more data are required not only for efficacy but also to address the long-term safety of cabergoline in these patients (84, 85).”
BackgroundThe Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Self-citationDopamine Agonists and the Risk of Cardiac-Valve Regurgitation
Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062222 · Cited by 718
Ilias, I., Torpy, D. J., Pacak, K., Mullen, N., Wesley, R. A., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2527 · Cited by 713
Self-citationBruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
Isidori, A. M., Kaltsas, G. A., Pozza, C., Frajese, V., Newell-Price, J., Reznek, R. H., Jenkins, P. J., Monson, J. P., Grossman, A. B., & Besser, G. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1542 · Cited by 522
Self-citationThe hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment
Lindsay, J. R., & Nieman, L. K. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0025 · Cited by 449 · cited 1×
“Detection of Cushing’s syndrome usually occurs late in gestation, and the diagnosis is complicated by the signs of normal pregnancy, such as central weight gain, facial plethora, and pigmentation (101) and the normal physiological changes in the maternal HPA axis.”
BackgroundSelf-citationPosterior retroperitoneoscopic adrenalectomy–results of 560 procedures in 520 patients
Walz, M. K., Alesina, P. F., Wenger, F. A., Deligiannis, A., Szuczik, E., Petersenn, S., Ommer, A., Groeben, H., Peitgen, K., Janssen, O. E., et al. (2006) · Surgery · doi:10.1016/j.surg.2006.07.039 · Cited by 425
Self-citationRisk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
Brada, M., Ford, D., Ashley, S., Bliss, J. M., Crowley, S., Mason, M., Rajan, B., & Traish, D. (1992) · BMJ · doi:10.1136/bmj.304.6838.1343 · Cited by 413 · cited 1×
“The risk of second tumor formation after pituitary radiation is considered to be in the range of 1–2% (39), but this may not be due to the radiotherapy per se.”
BackgroundThe use of ketoconazole as an inhibitor of steroid production
Oates, J. A., Wood, A. J. J., & Sonino, N. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171307 · Cited by 395
Self-citationTranssphenoidal Microsurgery for Cushing Disease: A Report of 216 Cases
Mampalam, T. J., Tyrrell, J. B., & Wilson, C. B. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-6-487 · Cited by 386
Estrada, J., Boronat, M., Mielgo, M., Magallón, R., Millán, I., Díez, S., Lucas, T., & Barceló, B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360303 · Cited by 383 · cited 1×
“It remains to be determined whether stereotactic radiosurgery will result in more rapid biochemical control than conventional radiation (35, 37, 38).”
BackgroundTranssphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term Results
Hammer, G. D., Tyrrell, J. B., Lamborn, K. R., Applebury, C. B., Hannegan, E. T., Bell, S., Rahl, R., Lu, A., & Wilson, C. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032180 · Cited by 374 · cited 1×
“However, total or partial hypophysectomy induces remission less often (approximately 70% of patients) than selective tumor resection (11, 19, 26, 28, 29) and is associated with a higher rate of complications and hypopituitarism than selective adenomectomy.”
BackgroundBoscaro, M., Barzon, L., Fallo, F., & Sonino, N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04172-6 · Cited by 350
Self-citationBochicchio, D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3114 · Cited by 344
Self-citationCushing’s Syndrome during Pregnancy: Personal Experience and Review of the Literature
Lindsay, J. R., Jonklaas, J., Oldfield, E. H., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2361 · Cited by 343 · cited 1×
“striction (21%), and stillbirth (6%) (102).”
Self-citationCushing’s Syndrome: important issues in diagnosis and management
Findling, J. W., & Raff, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0997 · Cited by 294
Pasireotide (SOM230): Development, mechanism of action and potential applications
Schmid, H. A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.09.006 · Cited by 290
Hofland, L. J., van der Hoek, J., Feelders, R., van Aken, M. O., van Koetsveld, P. M., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., de Herder, W. W., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01876 · Cited by 276
Self-citationDopamine Receptor Expression and Function in Corticotroph Pituitary Tumors
Pivonello, R., Ferone, D., de Herder, W. W., Kros, J. M., Del Basso De Caro, M. L., Arvigo, M., Annunziato, L., Lombardi, G., Colao, A., Hofland, L. J., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030837 · Cited by 271 · cited 2×
“5 mg/wk may be effective in treating a subset of patients with Cushing’s disease (82).”
BackgroundSelf-citationTrainer, P. J., Lawrie, H. S., Verhelst, J., Howlett, T. A., Lowe, D. G., Grossman, A. B., Savage, M. O., Afshar, F., & Besser, G. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00975.x · Cited by 267 · cited 1×
“However, total or partial hypophysectomy induces remission less often (approximately 70% of patients) than selective tumor resection (11, 19, 26, 28, 29) and is associated with a higher rate of complications and hypopituitarism than selective adenomectomy.”
BackgroundSelf-citationRisk factors and long-term outcome in pituitary-dependent Cushing's disease
Sonino, N. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2647 · Cited by 265 · cited 2×
“The recurrence rate in these patients is 5–10% at 5 yr and 10–20% at 10 yr (6, 11, 15–22), with young age (25 yr or younger) being a significant risk factor for relapse (22).”
BackgroundSelf-citationAtkinson, A. B., Kennedy, A., Wiggam, M. I., McCance, D. R., & Sheridan, B. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02380.x · Cited by 263
Rees, D. A., Hanna, F. W. F., Davies, J. S., Mills, R. G., Vafidis, J., & Scanlon, M. F. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01511.x · Cited by 261
Gamma Knife surgery for Cushing's disease
Jagannathan, J., Sheehan, J. P., Pouratian, N., Laws, E. R., Steiner, L., & Vance, M. L. (2007) · Journal of Neurosurgery · doi:10.3171/jns.2007.106.6.980 · Cited by 258
Self-citationGushing syndrome doe to ectopic adrenocorticotropic hormone secretion
Aniszewski, J. P., Young, W. F., Thompson, G. B., Grant, C. S., & van Heerden, J. A. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0032-5 · Cited by 232
Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease
Swearingen, B., Biller, B. M. K., Barker, F. G., Katznelson, L., Grinspoon, S., Klibanski, A., & Zervas, N. T. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00015 · Cited by 231
Self-citationAssié, G., Bahurel, H., Coste, J., Silvera, S., Kujas, M., Dugué, M.-A., Karray, F., Dousset, B., Bertherat, J., Legmann, P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1328 · Cited by 230
Self-citationFunctional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
Heaney, A. P., Fernando, M., Yong, W. H., & Melmed, S. (2002) · Nature Medicine · doi:10.1038/nm784 · Cited by 226
Self-citationRepeat transsphenoidal surgery for Cushing's disease
Friedman, R. B., Oldfield, E. H., Nieman, L. K., Chrousos, G. P., Doppman, J. L., Cutler, G. B., & Loriaux, D. L. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.71.4.0520 · Cited by 211
Self-citationTreatment of Cushing's Disease by o,p′DDD: Survey of 62 Cases
Luton, J. P., Mahoudeau, J. A., Bouchard, P., Thieblot, P., Hautecouverture, M., Simon, D., Laudat, M. H., Touitou, Y., & Bricaire, H. (1979) · New England Journal of Medicine · doi:10.1056/nejm197903013000903 · Cited by 210 · cited 1×
“Its mechanism of action also prevents the risk of escape phenomenon in response to the ACTH rise that occurs in Cushing’s disease when plasma cortisol is decreased (58).”
BackgroundYap, L. B., Turner, H. E., Adams, C. B. T., & Wass, J. A. H. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01444.x · Cited by 203
Self-citationThe Medical Treatment of Cushing's Syndrome
MILLER, J. W., & CRAPO, L. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-443 · Cited by 202
Ketoconazole treatment in Cushing’s syndrome: experience in 34 patients
Sonino, N., Boscaro, M., Paoletta, A., Mantero, F., & Zillotto, D. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03547.x · Cited by 201 · cited 1×
“According to human and animal studies, however, this phenomenon does not seem to involve a direct effect on ACTH secretion but rather an adjustment in the sensitivity of the HPA axis (47, 48, 50, 53, 54).”
BackgroundSelf-citationBatista, D. L., Zhang, X., Gejman, R., Ansell, P. J., Zhou, Y., Johnson, S. A., Swearingen, B., Hedley-Whyte, E. T., Stratakis, C. A., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1245 · Cited by 201
Self-citationGumbs, A. A., & Gagner, M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.010 · Cited by 197
Esposito, F., Dusick, J. R., Cohan, P., Moftakhar, P., McArthur, D., Wang, C., Swerdloff, R. S., & Kelly, D. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1204 · Cited by 192
Retinoic acid prevents experimental Cushing syndrome
Páez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Stalla, J., Grübler, Y., Missale, C., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11098 · Cited by 190 · cited 1×
“Although retinoic acid is effective at reducing ACTH in animal models (71) and in dogs with Cushing’s disease (72), the effective dose used is high and human clinical trial results are not currently available.”
BackgroundSelf-citationPPAR-γ receptor ligands: novel therapy for pituitary adenomas
Heaney, A. P., Fernando, M., & Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16575 · Cited by 184
Self-citationTranssphenoidal Surgery for Cushing's Disease
Fahlbusch, R., Buchfelder, M., & Müller, O. A. (1986) · Journal of the Royal Society of Medicine · doi:10.1177/014107688607900504 · Cited by 184
Self-citationTranssphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee, G. H., Mathias, D. B., James, R. A., & Kendall‐Taylor, P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01261.x · Cited by 182 · cited 3×
“Cushing’s Syndrome: Treatment Consensus J Clin Endocrinol Metab, July 2008, 93(7):2454–2462”
BackgroundInfluentialGamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease
Castinetti, F., Nagai, M., Dufour, H., Kuhn, J.-M., Morange, I., Jaquet, P., Conte-Devolx, B., Regis, J., & Brue, T. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02323 · Cited by 175
Pereira, A. M., van Aken, M. O., van Dulken, H., Schutte, P. J., Biermasz, N. R., Smit, J. W. A., Roelfsema, F., & Romijn, J. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030751 · Cited by 173
Magiakou, M. A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.1.131 · Cited by 173 · cited 1×
“Many pediatric patients will have persistent GH deficiency after successful transsphenoidal surgery (98, 99).”
BackgroundBlevins, L. S., Christy, J. H., Khajavi, M., & Tindall, G. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4525 · Cited by 167
Chen, J. C. T., Amar, A. P., Choi, S., Singer, P., Couldwell, W. T., & Weiss, M. H. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.5.0967 · Cited by 158
Use of Ketoconazole in the Treatment of Cushing’s Syndrome
LOLI, P., BERSELLI, M. E., & TAGLIAFERRI, M. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-6-1365 · Cited by 153 · cited 2×
“According to human and animal studies, however, this phenomenon does not seem to involve a direct effect on ACTH secretion but rather an adjustment in the sensitivity of the HPA axis (47, 48, 50, 53, 54).”
Backgroundvan der Hoek, J., Waaijers, M., van Koetsveld, P. M., Sprij-Mooij, D., Feelders, R. A., Schmid, H. A., Schoeffter, P., Hoyer, D., Cervia, D., Taylor, J. E., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00004.2005 · Cited by 152
Self-citationTranssphenoidal Surgery for Cushing's Disease: Endocrinological Follow-up Monitoring of 82 Patients
Shimon, I., Ram, Z., Cohen, Z. R., & Hadani, M. (2002) · Neurosurgery · doi:10.1097/00006123-200207000-00008 · Cited by 140
PPAR-γ receptor ligands: novel therapy for pituitary adenomas
Heaney, A. P., Fernando, M. A., & Melmed, S. K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316575 · Cited by 137
Self-citationPaediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances
Storr, H. L., Chan, L. F., Grossman, A. B., & Savage, M. O. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.03.005 · Cited by 136 · cited 1×
“1 yr) are most often seen in adolescents (95).”
BackgroundSelf-citationRepeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma
Benveniste, R. J., King, W. A., Walsh, J., Lee, J. S., Delman, B. N., & Post, K. D. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.102.6.1004 · Cited by 134
Clinical and Biochemical Characteristics of Adrenocorticotropin-Secreting Macroadenomas
Woo, Y. S., Isidori, A. M., Wat, W. Z., Kaltsas, G. A., Afshar, F., Sabin, I., Jenkins, P. J., Monson, J. P., Besser, G. M., & Grossman, A. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0070 · Cited by 134 · cited 1×
“Surgical success rates are lower in patients harboring macroadenomas and in patients with tumors that have invaded the dura (23).”
BackgroundSelf-citationSustained Remission of Cushing's Disease with Mitotane and Pituitary Irradiation
SCHTEINGART, D. E., TSAO, H. S., TAYLOR, C. I., MCKENZIE, A., VICTORIA, R., & THERRIEN, B. A. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-5-613 · Cited by 131
Mifepristone (RU 486) in Cushing's syndrome
Johanssen, S., & Allolio, B. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0458 · Cited by 122 · cited 1×
“Treatment with the glucocorticoid receptor antagonist mifepristone (RU486) has been reported in fewer than 20 patients with ectopic ACTH secretion, and its use for this indication is currently investigational (62).”
BackgroundRetinoic Acid as a Novel Medical Therapy for Cushing’s Disease in Dogs
Castillo, V., Giacomini, D., Páez-Pereda, M., Stalla, J., Labeur, M., Theodoropoulou, M., Holsboer, F., Grossman, A. B., Stalla, G. K., & Arzt, E. (2006) · Endocrinology · doi:10.1210/en.2006-0414 · Cited by 121 · cited 1×
“Although retinoic acid is effective at reducing ACTH in animal models (71) and in dogs with Cushing’s disease (72), the effective dose used is high and human clinical trial results are not currently available.”
BackgroundSelf-citationThompson, S. K., Hayman, A. V., Ludlam, W. H., Deveney, C. W., Loriaux, D. L., & Sheppard, B. C. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251578.03883.2f · Cited by 117
Proton Stereotactic Radiotherapy for Persistent Adrenocorticotropin-Producing Adenomas
Petit, J. H., Biller, B. M. K., Yock, T. I., Swearingen, B., Coen, J. J., Chapman, P., Ancukiewicz, M., Bussiere, M., Klibanski, A., & Loeffler, J. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1220 · Cited by 117 · cited 1×
“It remains to be determined whether stereotactic radiosurgery will result in more rapid biochemical control than conventional radiation (35, 37, 38).”
BackgroundSelf-citationEstrada, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5695 · Cited by 111
Lamberts, S. W. J., Uitterlinden, P., & Klijn, J. M. G. (1989) · Acta Endocrinologica · doi:10.1530/acta.0.1200760 · Cited by 109
LONG‐TERM FOLLOW‐UP OF LOW‐DOSE EXTERNAL PITUITARY IRRADIATION FOR CUSHING'S DISEASE
LITTLEY, M. D., SHALET, S. M., BEARDWELL, C. G., AHMED, S. R., & SUTTON, M. L. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03883.x · Cited by 105
Pouratian, N., Prevedello, D. M., Jagannathan, J., Lopes, M. B., Vance, M. L., & Laws, E. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0208 · Cited by 104
Self-citationWinquist, E. W., Laskey, J., Crump, M., Khamsi, F., & Shepherd, F. A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.157 · Cited by 103 · cited 1×
“very severe symptoms of Cushing’s syndrome (92, 93).”
BackgroundChow, J. T., Thompson, G. B., Grant, C. S., Farley, D. R., Richards, M. L., & Young, W. F. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03082.x · Cited by 102
Storr, H. L., Plowman, P. N., Carroll, P. V., François, I., Krassas, G. E., Afshar, F., Besser, G. M., Grossman, A. B., & Savage, M. O. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021032 · Cited by 98 · cited 1×
“If surgery is unsuccessful, radiotherapy may be more effective than it is in adult patients, with effective cure often occurring within 1 yr (97).”
BackgroundSelf-citationMEDICAL THERAPY FOR CUSHING'S DISEASE
Sonino, N., & Boscaro, M. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70064-5 · Cited by 93
Self-citationCabergoline plus Lanreotide for Ectopic Cushing's Syndrome
Pivonello, R., Ferone, D., Lamberts, S. W. J., & Colao, A. (2005) · New England Journal of Medicine · doi:10.1056/nejm200506093522322 · Cited by 91
Self-citationThe Efficacy of Linear Accelerator Radiosurgery in the Management of Patients with Cushing’s Disease
Devin, J. K., Allen, G. S., Cmelak, A. J., Duggan, D. M., & Blevins, L. S. (2004) · Stereotactic and Functional Neurosurgery · doi:10.1159/000083476 · Cited by 90
Final adult height and body mass index after cure of paediatric Cushing's disease
Davies, J. H., Storr, H. L., Davies, K., Monson, J. P., Besser, G. M., Afshar, F., Plowman, P. N., Grossman, A. B., & Savage, M. O. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02244.x · Cited by 88 · cited 2×
“In addition, although normalization of decreased bone mineral density generally occurs in the long term, other metabolic abnormalities, particularly obesity, may remain problematic (100).”
BackgroundSelf-citationPersistent and Recurrent Hypercortisolism After Transsphenoidal Surgery for Cushing’s Disease
Knappe, U. J., & Lüdecke, D. K. (1996) · Springer eBooks · doi:10.1007/978-3-7091-9450-8_10 · Cited by 85
Krakoff, J. A., Koch, C. A., Calis, K. A., Alexander, R. H., & Nieman, L. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7870 · Cited by 85 · cited 1×
“sparing diuretics are valuable and, in extremis, iv etomidate can be very useful (59, 94).”
BackgroundSelf-citationGiraldi, F. P., Scaroni, C., Arvat, E., De Martin, M., Giordano, R., Albiger, N., Leao, A. A. S., Picu, A., Mantero, F., & Cavagnini, F. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02452.x · Cited by 84
Effect of Pioglitazone on Adrenocorticotropic Hormone and Cortisol Secretion in Cushing’s Disease
Suri, D., & Weiss, R. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1746 · Cited by 84
The Nelson's syndrome... revisited
Assié, G., Bahurel-Barrera, H., Bertherat, J. Y., Kujas, M., Legmann, P., & BERTAGNA, X. Y. (2004) · Pituitary · doi:10.1007/s11102-005-1403-y · Cited by 82
Self-citationGreening, J. E., Brain, C. E., Perry, L. A., Mushtaq, I., Sales Marques, J., Grossman, A. B., & Savage, M. O. (2005) · Hormone Research in Paediatrics · doi:10.1159/000088587 · Cited by 82
Self-citationDe Tommasi, C., Vance, M. L., Okonkwo, D. O., Diallo, A., & Laws, E. R. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.103.5.0825 · Cited by 81
Self-citationMedical Management of Pituitary Adenomas: The Special Case of Management of the Pregnant Woman
Bronstein, M. D., Salgado, L. R., & Musolino, N. R. D. C. (2002) · Pituitary · doi:10.1023/a:1022364514971 · Cited by 79
Hána, V., Dokoupilová, M., Marek, J., & Plavka, R. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01055.x · Cited by 77
Blevins, L. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.63 · Cited by 77
Trainer, P. J. (2002) · Seminars in Reproductive Medicine · doi:10.1055/s-2002-36710 · Cited by 76
Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing’s disease
Storr, H. L., Afshar, F., Matson, M., Sabin, I., Davies, K. M., Evanson, J., Plowman, P. N., Besser, G. M., Monson, J. P., Grossman, A. B., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01921 · Cited by 72 · cited 1×
“Transsphenoidal surgery by an experienced surgeon is the preferred primary therapy of pediatric Cushing’s disease, with cure rates similar to those seen in adult patients (96).”
BackgroundSelf-citationAmbrosi, B., Bochicchio, D., Fadin, C., Colombo, P., & Faglia, G. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03349555 · Cited by 71
Adrenal Disorders in Pregnancy
Lindsay, J. R., & Nieman, L. K. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.09.010 · Cited by 63
Self-citationRobert, F., & Hardy, J. (1991) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80157-3 · Cited by 61 · cited 1×
“However, total or partial hypophysectomy induces remission less often (approximately 70% of patients) than selective tumor resection (11, 19, 26, 28, 29) and is associated with a higher rate of complications and hypopituitarism than selective adenomectomy.”
BackgroundBlanco, C., Maqueda, E., Rubio, J. A., & Rodríguez, Á. A. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344091 · Cited by 61
Surgical Treatment of Recurrent Cushing's Disease
Hofmann, B. M., Hlavac, M., Kreutzer, J., Grabenbauer, G., & Fahlbusch, R. (2006) · Neurosurgery · doi:10.1227/01.neu.0000215945.26764.92 · Cited by 56
Reina, L. J., Leal-Cerro, A., Garcia, J., Garcia-Luna, P. P., Astorga, R., & Bernal, G. (1989) · Acta Endocrinologica · doi:10.1530/acta.0.1210185 · Cited by 55 · cited 1×
“Taken together, these findings argue against an additional site of inhibition at the pituitary level, although it was suggested by in vitro studies of pituitary corticotrophs (57).”
ResultRegulation of CRH-induced secretion of ACTH and corticosterone by SOM230 in rats
Silva, A. P., Schoeffter, P., Weckbecker, G., Bruns, C., & Schmid, H. A. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01998 · Cited by 54
Treatment of Cushing’s Disease: A Retrospective Clinical Study of the Latest 100 Cases
Hofmann, B. M., & Fahlbusch, R. (2006) · Frontiers of Hormone Research · doi:10.1159/000091580 · Cited by 50
Emery, M. N., Leontiou, C. A., BONNER, S. E., Merulli, C., Nanzer, A. M., Muşat, M., Galloway, M., Powell, M. P., Nikookam, K., Korbonits, M., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02610.x · Cited by 49
Self-citationTREATMENT OF CUSHING'S SYNDROME WITH THE LONG‐ACTING SOMATOSTATIN ANALOGUE SMS 201‐995 (SANDOSTATIN)
Invitti, C., Martin, M., Brunani, A., Piolini, M., & Cavagnini, F. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00867.x · Cited by 44
BOSCARO, M., SONINO, N., RAMPAZZO, A., & MANTERO, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb01174.x · Cited by 43 · cited 2×
“According to human and animal studies, however, this phenomenon does not seem to involve a direct effect on ACTH secretion but rather an adjustment in the sensitivity of the HPA axis (47, 48, 50, 53, 54).”
BackgroundSelf-citationIneffectiveness of Rosiglitazone Therapy in Nelson’s Syndrome
Munir, A., Song, F., Ince, P., Walters, S. J., Ross, R., & Newell-Price, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2005 · Cited by 42
Self-citationEffect of the serotonin antagonists ritanserin and ketanserin in Cushing’s disease
Sonino, N., Fava, G. A., Fallo, F., Franceschetto, A., Belluardo, P., & Boscaro, M. (2000) · Pituitary · doi:10.1023/a:1009986822146 · Cited by 41 · cited 1×
“-aminobutyric acid (GABA) agonists are generally ineffective and are not routinely recommended (86).”
BackgroundSelf-citationCarroll, P. V., Monson, J. P., Grossman, A. B., Besser, G. M., Plowman, P. N., Afshar, F., & Savage, M. O. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01922.x · Cited by 40 · cited 1×
“Many pediatric patients will have persistent GH deficiency after successful transsphenoidal surgery (98, 99).”
BackgroundSelf-citationSomatostatin analogs in ectopic corticotropin production
von Werder, K., Müller, O. A., & Stalla, G. K. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90107-9 · Cited by 40
Self-citationMullan, K., Leslie, H., McCance, D. R., Sheridan, B., & Atkinson, A. B. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02501.x · Cited by 40
Trainer, P. J., Eastment, C., Grossman, A. B., Wheeler, M. J., Perry, L., & Besser, G. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02391.x · Cited by 39 · cited 1×
“Blood samples are taken at 0900, 1200, 1500, 1800, and 2100 h, and the mean cortisol levels are calculated; previous studies using an isotopic dilution production rate technique have established that a mean level of 150–300 nmol/liter ( 5–10 g/dl) is equivalent to a normal production rate (63).”
MethodSelf-citationKrakoff, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4104 · Cited by 38
Pharmacologic Management of Cushing Syndrome: New Targets for Therapy
Sonino, N., Boscaro, M., & Fallo, F. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504020-00003 · Cited by 36
Self-citationMansi, L., Rambaldi, P. F., Panza, N., Esposito, D., Esposito, V., & Pastore, V. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370688 · Cited by 36
The diagnosis and differential diagnosis of endogenous Cushing?s syndrome
Makras, P., Toloumis, G., Papadogias, D., Kaltsas, G., & Besser, M. (2006) · HORMONES · doi:10.14310/horm.2002.11189 · Cited by 35
Prolonged remission in florid Cushing’s syndrome following metyrapone treatment
BEARDWELL, C. G., ADAMSON, A. R., & SHALET, S. M. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00638.x · Cited by 34
Johnson, T. N., & Canada, T. W. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h365 · Cited by 32
Effect of ketoconazole on adrenocorticotrophic hormone secretion in vitro and in vivo
Burrin, J. M., Yeo, T., Ashby, M. J., & Bloom, S. R. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1080037 · Cited by 31 · cited 1×
“According to human and animal studies, however, this phenomenon does not seem to involve a direct effect on ACTH secretion but rather an adjustment in the sensitivity of the HPA axis (47, 48, 50, 53, 54).”
BackgroundSCHTEINGART, D. E. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30373-6 · Cited by 31
EFFECT OF ETOMIDATE ON HYPERCORTISOLISM DUE TO ECTOPIC ACTH PRODUCTION
Gärtner, R., Albrecht, M. C., & Müller, O. A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90811-1 · Cited by 22
[Cushing's disease and corticotrophic adenoma: results of pituitary microsurgery].
Stevenaert, A., Perrin, G., Martin, D., & Beckers, A. M. (2002) · PubMed · Cited by 15
Research works printed but not linked: 1
- 52. Sonino N, Boscaro M, Ambroso G, Merola G, Mantero F 1986 Prolonged - treatment of Cushing's disease with metyrapone and aminoglutethimide. IRCS Med Sci 14:485-486
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationConsensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
“6,7 140 Patients in remission require glucocorticoid replacement until HPA axis recovery.”
Self-citationComplications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., De Martino, M. C., Newell-Price, J., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 641
Self-citationA 12-month phase 3 study of pasireotide in Cushing's disease
Colao, A., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Schoenherr, U., Dipl.-Biol., Mills, D., Salgado, L. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105743 · Cited by 628
“Asthenia 2 (2) 13 (16) 2 (2) 5 (6) 4 (2) 18 (11)”
Self-citationMicko, A. S. G., Wöhrer, A., Wolfsberger, S., & Knosp, E. (2015) · Journal of Neurosurgery · doi:10.3171/2014.12.jns141083 · Cited by 577
“We used the most recent consensus statements 5,6, 25,53 to define ER.”
Method
Metadata
- Authors
- Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., Klibanski, A., Lacroix, A., Lindsay, J. R., Newell-Price, J., Nieman, L. K., Petersenn, S., Sonino, N., Stalla, G. K., Swearingen, B., Vance, M. L., Wass, J. A. H., & Boscaro, M.
- Affiliations
- Massachusetts General Hospital (US)
- St Bartholomew's Hospital (GB)
- Queen Elizabeth Hospital Birmingham (GB)
- Cedars-Sinai Medical Center (US)
- Hôpital Cochin (FR)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Naples Federico II (IT)
- Radboud University Nijmegen (NL)
- Erasmus MC (NL)
- Centre Hospitalier de l’Université de Montréal (CA)
- Altnagelvin Area Hospital (GB)
- University of Sheffield (GB)
- National Institutes of Health (US)
- University of Duisburg-Essen (DE)
- University of Padua (IT)
- Max Planck Institute of Psychiatry (DE)
- University of Virginia Health System (US)
- Churchill Hospital (GB)
- Marche Polytechnic University (IT)
- Corresponding author
- Boscaro, M.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-07-01
- Volume
- 93
- Issue
- 7
- Pages
- 2454-2462
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3214276
- OpenAlex
- W2147573461
- Cited by
- 853
- References
- 107
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 26 · 2023: 29 · 2022: 40 · 2021: 35 · 2020: 47 · 2019: 59 · 2018: 42 · 2017: 40 · 2016: 44 · 2015: 91 · 2014: 69 · 2013: 74 · 2012: 70
- FWCI
- 38.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Radboud Repository (Radboud University) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Max Planck Institute for Plasma Physics (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (Z01HD008833)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- ACTH-dependent Cushing's syndrome, Cushing's disease, ectopic ACTH syndrome, Nelson's syndrome, transsphenoidal surgery, pituitary tumor resection, radiotherapy, medical therapy, bilateral adrenalectomy, remission criteria, consensus statement
- MeSH terms
- ACTH Syndrome, Ectopic, Adrenal Insufficiency, Adrenalectomy, Adrenocorticotropic Hormone, Cushing Syndrome, Humans, Hypophysectomy, Metyrapone, Mitotane, Nelson Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.